© National Cancer Institute
|
About the disease |
Acute myelogenous leukemia (AML) is a progressively rapid blood and bone marrow cancer that affects granulocytes or white blood cells.i, ii |
|
Cause |
Although the exact cause of AML is unclear, several risk factors exist. These include |
|
Diseaseburden |
AML can affect both children and adults. Estimates suggest there are more than 13,000 new cases annually in the US alone.iii |
|
Vaccine status |
In development for the treatment of acute myelogenous leukemia. |
|
Reference |
i. US Centers for Disease Control and Prevention. Blood Cancers. ii. US Centers for Disease Control and Prevention. Leukemia. iii. US National Cancer Institute. What You Need To Know About™ Leukemia. |
15 May 2013,
Scientific and regulatory experts meet in Moscow to explore harmonized approaches for...
18 April 2013,
Vaccine experts recommend practical actions to support vaccine innovation and access around the...
20 May 2013, Geneva, Switzerland
The Annual IFPMA Reception on the occasion of the 66th World Health Assembly

UPDATED! Developing World Health Partnerships Directory
The research-based pharmaceutical industry engages in a wide range of public-private partnerships...

IFPMA Code of Practice
Expanded IFPMA Code of Practice updates ethical and professional standards for interacting with...

IFPMA Clinical Trials Portal and Joint Positions on Clinical Trial Results Publication and...
Important online sources of clinical trials information
